Prices are updated after-hours

Vyant Bio Inc

VYNT | $0.194 -8.51% 19K

(0.0% 1d) (0.0% 1m) (-48.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1671.02% volume)
Earnings Calendar: 2023-03-29
Market Cap: $ 1,227,778
https://www.vyantbio.com
Sec Filling | Patents | n/a employees

(US) Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.

add to watch list Paper trade email alert is off

Cano Health Inc - Class A

CANO | $2.3 -49.13% 21K

Health Care and Social Assistan...

(0.0% 1d) (0.0% 1m) (105.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 6,641,498
https://canohealth.com
Sec Filling | Patents | 2200 employees

(US) Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico.

add to watch list Paper trade email alert is off

Clubhouse Media Group, Inc.

CMGR | $0.0003 -50.0% 77K

Health Care and Social Assistan...

(0.0% 1d) (50.0% 1m) (200.0% 1y) (0.0% 2d) (0.0% 3d) (25.0% 7d) (13.19% volume)
Earnings Calendar:
Market Cap: $ 4,911,654

Sec Filling | Patents | 1 employees

the clubhouse group, a wohg company, is a best-in-class and first of its kind company with subsidiaries that which include an international chain of content creator collaborative studio spaces, doiyen - a talent management company, and woh brands, a brand incubator and pre-seed fund.

add to watch list Paper trade email alert is off

Biora Therapeutics Inc

BIOR | $0.6199 -2.99% -3.08% 180K

Health Care and Social Assistan...

(0.0% 1d) (-47.5% 1m) (-74.7% 1y) (0.0% 2d) (4.9% 3d) (4.9% 7d) (139.24% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 22,244,394
https://www.progenity.com
Sec Filling | Patents | 642 employees

(US) Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.

treatment diagnostics

add to watch list Paper trade email alert is off

Splash Beverage Group Inc

SBEV | $0.329 2.49% 0.0% 78K

Health Care and Social Assistan...

(0.0% 1d) (-34.6% 1m) (-74.4% 1y) (0.0% 2d) (-3.0% 3d) (-5.9% 7d) (17.07% volume)
Earnings Calendar:
Market Cap: $ 14,847,667
https://splashbeveragegroup.com
Sec Filling | Patents | 9 employees

Splash Beverage Group specializes in manufacturing, distribution, sales & marketing of various beverages across multiple channels. SBEV operates in both the non-alcoholic and alcoholic beverage segments which they believe leverages efficiencies and dilutes risk. SBEV believes its business model is unique as it ONLY develops/accelerates brands it perceives to have highly visible pre-existing brand awareness or pure category innovation.

brands

add to watch list Paper trade email alert is off

ModivCare Inc

MODV 4 | $24.78 10.04% 9.12% 280K

Health Care and Social Assistan...

(0.0% 1d) (-4.5% 1m) (-66.7% 1y) (0.0% 2d) (2.4% 3d) (5.9% 7d) (33.44% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 351,829,934
https://www.prscholdings.com/
Sec Filling | Patents | 7100 employees

(US) Providence Service Corporation is an Atlanta, Georgia-based American social services corporation listed on the NASDAQ. Providence Service Corporation was established in 1997. It has a payroll of approximately 7,100. Its Chairman is Christopher S. Shackelton and its current Chief Executive Officer is Daniel E. Greenleaf.

add to watch list Paper trade email alert is off

Viridian Therapeutics Inc

VRDN | $13.04 -8.49% -9.28% 770K

Health Care and Social Assistan...

(0.0% 1d) (-18.8% 1m) (-49.5% 1y) (0.0% 2d) (-0.3% 3d) (-6.0% 7d) (-33.73% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 818,489,113
http://www.miragen.com/
Sec Filling | Patents | 27 employees

(US) Viridian Therapeutics is a biotechnology company advancing new treatments for patients suffering from serious diseases but underserved by today’s therapies. Viridian’s most advanced program, VRDN-001, is a clinical-stage anti-IGF-1R monoclonal antibody in development for thyroid eye disease (TED). Viridian is headquartered in Boulder, Colorado , with research and development operations in Waltham, Massachusetts.

treatment antibody

add to watch list Paper trade email alert is off

U.S. NeuroSurgical Holdings, Inc.

USNU 4 | $0.75 -75.07% 200

Health Care and Social Assistan...

(0.0% 1d) (-6.3% 1m) (837.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (69.49% volume)
Earnings Calendar:
Market Cap: $ 5,919,139

Sec Filling | Patents | 3 employees

us neurosurgical inc (usnu) is a hospital and health care company located in 2400 research blvd # 325, rockville, maryland, united states.

add to watch list Paper trade email alert is off

BioCorRx Inc.

BICX | $0.75 201.91% 4.2K

Health Care and Social Assistan...

(0.0% 1d) (-15.7% 1m) (-59.0% 1y) (0.0% 2d) (0.0% 3d) (-49.0% 7d) (57.08% volume)
Earnings Calendar:
Market Cap: $ 6,672,828
https://www.biocorrx.com/
Sec Filling | Patents | 3 employees

(United States) a company that changes lives biocorrx® is a leading edge healthcare solutions company focused on improving the lives of those struggling with alcohol and opioid addiction. designed to treat alcoholism and certain opioid addictions, the biocorrx® recovery program is used by a network of independently owned and operated treatment centers located throughout the united states. the program consists of a proprietary long-lasting implant of the fda approved medication, naltrexone, which is proven to substantially reduce cravings for drugs and alcohol. it's a high-quality, comprehensive and cost- effective recovery program built on a strong foundation of experience and practice, allowing for an improved quality of life for recovering addicts.

education

add to watch list Paper trade email alert is off